{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:55:13Z","timestamp":1785786913307,"version":"3.56.0"},"reference-count":45,"publisher":"The Journal of Rheumatology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>We aimed to identify the (1) demographic\/clinical characteristics, (2) medication usage trends, (3) variables associated with worse disease activity, and (4) characteristics of patients with persistent chronic arthritis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry\u2019s systemic juvenile idiopathic arthritis (sJIA) cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Demographics, disease activity measures, and medications at enrollment of patients with sJIA in the CARRA Registry were analyzed using descriptive statistics. Multivariate analyses were conducted to identify associations with increased disease activity. Medication usage frequencies were calculated by year.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>There were 528 patients with sJIA enrolled in the registry (2010\u20132013). There were 435 patients who had a complete dataset; of these, 372 met the International League of Associations for Rheumatology criteria and were included in the analysis. At enrollment, median disease duration and joint count were 3.7 years and 0, respectively; 16.4% had a rash and 6.7% had a fever. Twenty-six percent were taking interleukin 1 (IL-1) inhibitors and 29% glucocorticoids. Disease-modifying antirheumatic drugs and tumor necrosis factor inhibitors use decreased, while IL-6 inhibitor use increased between 2010 and 2013. African American patients had worse joint counts (p = 0.003), functional status (p = 0.01), and physician\u2019s global assessment (p = 0.008). Of the 255 subjects with &gt; 2 years of disease duration, 56% had no arthritis or systemic symptoms, while 32% had persistent arthritis only.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Most patients in the largest sJIA cohort reported to date had low disease activity. Practice patterns for choice of biologic agents appeared to change over the study period. Nearly one-third had persistent arthritis without systemic symptoms &gt; 2 years after onset. African Americans were associated with worse disease activity. Strategies are needed to improve outcomes in subgroups with poor prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.150997","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T04:57:22Z","timestamp":1466053042000},"page":"1755-1762","source":"Crossref","is-referenced-by-count":48,"title":["The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010\u20132013"],"prefix":"10.3899","volume":"43","author":[{"given":"Ginger","family":"Janow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Schanberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soko","family":"Setoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Hasselblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Mellins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayfel","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CARRA Legacy Registry Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2016,6,15]]},"reference":[{"key":"2018112909361040000_43.9.1755.1","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2012.3"},{"key":"2018112909361040000_43.9.1755.2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.85.5.421"},{"key":"2018112909361040000_43.9.1755.3","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909361040000_43.9.1755.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.21774"},{"key":"2018112909361040000_43.9.1755.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112802"},{"key":"2018112909361040000_43.9.1755.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205099"},{"key":"2018112909361040000_43.9.1755.7","doi-asserted-by":"publisher","DOI":"10.1002\/art.33342"},{"key":"2018112909361040000_43.9.1755.8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21888"},{"key":"2018112909361040000_43.9.1755.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.30128"},{"key":"2018112909361040000_43.9.1755.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.38699"},{"key":"2018112909361040000_43.9.1755.11","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2012-001042"},{"key":"2018112909361040000_43.9.1755.12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120110"},{"key":"2018112909361040000_43.9.1755.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201991"},{"key":"2018112909361040000_43.9.1755.14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","article-title":"Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis","volume":"64","author":"DeWitt","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2018112909361040000_43.9.1755.15","first-page":"2275","article-title":"Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria","volume":"30","author":"Berntson","year":"2003","journal-title":"J Rheumatol"},{"key":"2018112909361040000_43.9.1755.16","first-page":"1377","article-title":"Epidemiology of juvenile idiopathic arthritis in Alsace, France","volume":"33","author":"Danner","year":"2006","journal-title":"J Rheumatol"},{"key":"2018112909361040000_43.9.1755.17","first-page":"99","article-title":"Epidemiology of juvenile chronic arthritis in northern Norway: a ten-year retrospective study","volume":"16","author":"Moe","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909361040000_43.9.1755.18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1542\/peds.90.6.950","article-title":"Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population study","volume":"90","author":"G\u00e4re","year":"1992","journal-title":"Pediatrics"},{"key":"2018112909361040000_43.9.1755.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.1997.tb03593.x"},{"key":"2018112909361040000_43.9.1755.20","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130924"},{"key":"2018112909361040000_43.9.1755.21","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120386"},{"key":"2018112909361040000_43.9.1755.22","first-page":"2322","article-title":"Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis","volume":"33","author":"Sandborg","year":"2006","journal-title":"J Rheumatol"},{"key":"2018112909361040000_43.9.1755.23","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C"},{"key":"2018112909361040000_43.9.1755.24","first-page":"491","article-title":"Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years","volume":"27","author":"Lomater","year":"2000","journal-title":"J Rheumatol"},{"key":"2018112909361040000_43.9.1755.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.38615"},{"issue":"Suppl 10","key":"2018112909361040000_43.9.1755.26","first-page":"959","article-title":"Results from the Childhood Arthritis and Rheumatology Research Alliance systemic JIA Consensus Treatment Plans pilot study","volume":"67","author":"Kimura","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2018112909361040000_43.9.1755.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204641"},{"key":"2018112909361040000_43.9.1755.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.1993.tb03088.x"},{"key":"2018112909361040000_43.9.1755.29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.9.876"},{"key":"2018112909361040000_43.9.1755.30","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6942(02)90233-0"},{"issue":"Suppl 2","key":"2018112909361040000_43.9.1755.31","first-page":"279","article-title":"Prognosis of juvenile rheumatoid arthritis","volume":"20","author":"Hanson","year":"1977","journal-title":"Arthritis Rheum"},{"key":"2018112909361040000_43.9.1755.32","first-page":"91","article-title":"[Prognosis of the systemic forms of juvenile chronic arthritis. Apropos of 100 cases]","volume":"41","author":"Prieur","year":"1984","journal-title":"Arch Fr Pediatr"},{"key":"2018112909361040000_43.9.1755.33","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1033897"},{"key":"2018112909361040000_43.9.1755.34","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442095"},{"key":"2018112909361040000_43.9.1755.35","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1671"},{"key":"2018112909361040000_43.9.1755.36","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090952"},{"key":"2018112909361040000_43.9.1755.37","doi-asserted-by":"publisher","DOI":"10.1002\/art.20944"},{"key":"2018112909361040000_43.9.1755.38","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20460"},{"key":"2018112909361040000_43.9.1755.39","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22087"},{"key":"2018112909361040000_43.9.1755.40","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121147"},{"key":"2018112909361040000_43.9.1755.41","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-125"},{"key":"2018112909361040000_43.9.1755.42","doi-asserted-by":"publisher","DOI":"10.1002\/art.27431"},{"key":"2018112909361040000_43.9.1755.43","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100726"},{"key":"2018112909361040000_43.9.1755.44","first-page":"343","article-title":"Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR)","volume":"35","author":"Behrens","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909361040000_43.9.1755.45","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-eular.6735"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.150997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T17:28:49Z","timestamp":1718645329000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.150997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,15]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,1]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.3899\/jrheum.150997"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.150997","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,15]]}}}